Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Epirubicin and Docetaxel Versus Epirubicin in Node Positive Postmenopausal Breast Cancer
NCT00010140Phase 3Unknown
- Sponsor
- International Collaborative Cancer Group
- Start
- Aug 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by International Collaborative Cancer Group. Status: unknown.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00010140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010140.